Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perampanel Retention Study in Epilepsy
NCT03288129Phase 4Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Aug 2017
- Primary completion
- Apr 2021
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of perampanel in epilepsy, sponsored by Eisai Co., Ltd.. Started Aug 2017; status: completed.
02
Drugs
perampanel
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT03288129.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03288129.